Gene · 4837
Papers1,489
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,489
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Differential molecular mechanisms of substrate recognition by selenium methyltransferases, INMT and TPMT, in selenium detoxification and excretion. | J Biol Chem | 2024 | 38159853 | PubTator, text mining | PubMed |
| NNMT/1-MNA Promote Cell-Cycle Progression of Breast Cancer by Targeting UBC12/Cullin-1-Mediated Degradation of P27 Proteins. | Adv Sci (Weinh) | 2024 | 38126621 | PubTator, text mining | PubMed |
| Enhancing nicotinamide N-methyltransferase bisubstrate inhibitor activity through 7-deazaadenosine and linker modifications. | Bioorg Chem | 2024 | 38048700 | PubTator, text mining | PubMed |
| Differential properties of Janus kinase inhibitors in the treatment of immune-mediated inflammatory diseases. | Rheumatology (Oxford) | 2024 | 37624925 | PubTator, text mining | PubMed |
| Impact of ferroptosis-related risk genes on macrophage M1/M2 polarization and prognosis in glioblastoma. | Front Cell Neurosci | 2023 | 38283752 | PubTator, text mining | PubMed |
| The Role of Sirtuin 6 in the Deacetylation of Histone Proteins as a Factor in the Progression of Neoplastic Disease. | Int J Mol Sci | 2023 | 38203666 | PubTator, text mining | PubMed |
| The Role of Nicotinamide as Chemo-Preventive Agent in NMSCs: A Systematic Review and Meta-Analysis. | Nutrients | 2023 | 38201930 | PubTator, text mining | PubMed |
| Molecular Insight into Gastric Cancer Invasion-Current Status and Future Directions. | Cancers (Basel) | 2023 | 38201481 | PubTator, text mining | PubMed |
| Deciphering Urogenital Cancers through Proteomic Biomarkers: A Systematic Review and Meta-Analysis. | Cancers (Basel) | 2023 | 38201450 | PubTator, text mining | PubMed |
| Advances in the role of microRNAs associated with the PI3K/AKT signaling pathway in lung cancer. | Front Oncol | 2023 | 38169723 | PubTator, text mining | PubMed |
| Molecular Mechanisms of IL18 in Disease. | Int J Mol Sci | 2023 | 38139000 | PubTator, text mining | PubMed |
| Molecular, Cellular, and Technical Aspects of Breast Cancer Cell Lines as a Foundational Tool in Cancer Research. | Life (Basel) | 2023 | 38137912 | PubTator, text mining | PubMed |
| A Review of Advanced Cutaneous Melanoma Therapies and Their Mechanisms, from Immunotherapies to Lysine Histone Methyl Transferase Inhibitors. | Cancers (Basel) | 2023 | 38136297 | PubTator, text mining | PubMed |
| Tanshinone IIA: a Chinese herbal ingredient for the treatment of atherosclerosis. | Front Pharmacol | 2023 | 38108067 | PubTator, text mining | PubMed |
| Human-derived air-liquid interface cultures decipher Alzheimer's disease-SARS-CoV-2 crosstalk in the olfactory mucosa. | J Neuroinflammation | 2023 | 38098019 | PubTator, text mining | PubMed |
| Epigenetic Regulation in Oral Squamous Cell Carcinoma Microenvironment: A Comprehensive Review. | Cancers (Basel) | 2023 | 38067304 | PubTator, text mining | PubMed |
| A unique binding pocket induced by a noncanonical SAH mimic to develop potent and selective PRMT inhibitors. | Acta Pharm Sin B | 2023 | 38045046 | PubTator, text mining | PubMed |
| Discovery of a novel lipid metabolism-related gene signature to predict outcomes and the tumor immune microenvironment in gastric cancer by integrated analysis of single-cell and bulk RNA sequencing. | Lipids Health Dis | 2023 | 38042786 | PubTator, text mining | PubMed |
| Construction of EMT related prognostic signature for kidney renal clear cell carcinoma, through integrating bulk and single-cell gene expression profiles. | Front Pharmacol | 2023 | 38035023 | PubTator, text mining | PubMed |
| Molecular subtyping and characterization of clear cell renal cell carcinoma by tumor differentiation trajectories. | iScience | 2023 | 38034348 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4837/papers?page=10